We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-17.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$47.7B
AUM Growth
-$12.1B
(-20%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
20.23%
Holding
2,980
New
31
Increased
2,361
Reduced
322
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$22.7M |
| 2 |
Centene
CNC
|
+$20M |
| 3 |
Ingersoll Rand
IR
|
+$18.4M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$16.8M |
| 5 |
Digital Realty Trust
DLR
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$70.6M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$34.9M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$27M |
| 4 |
Netflix
NFLX
|
+$25.9M |
| 5 |
Howmet Aerospace
HWM
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.47% |
| 2 | Healthcare | 14.79% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAG
1976
DELISTED
AMAG Pharmaceuticals
AMAG
| $808K | ﹤0.01% |
130,779
+10,590
| +9% | +$93.3K |
|
|
AERI
1977
DELISTED
Aerie Pharmaceuticals
AERI
| $807K | ﹤0.01% |
59,758
-850
| -1% | -$16.1K |
|
1978
Sonos
SONO
$1.83B
| $797K | ﹤0.01% |
93,931
+7,077
| +8% | +$87.4K |
|
|
FFG
1979
DELISTED
FBL Financial Group
FFG
| $792K | ﹤0.01% |
16,961
-7,768
| -31% | -$394K |
|
|
SHOE
1980
Shoe Station Group
SHOE
$437M
| $790K | ﹤0.01% |
76,030
+2,676
| +4% | +$42.1K |
|
1981
CVR Energy
CVI
$3.26B
| $789K | ﹤0.01% |
47,706
+1,465
| +3% | +$44.1K |
|
|
AAMI
1982
Acadian Asset Management
AAMI
$3.22B
| $786K | ﹤0.01% |
122,991
+7,235
| +6% | +$62.5K |
|
1983
Upland Software
UPLD
$14.5M
| $784K | ﹤0.01% |
2,923
+27
| +0.9% | +$9.76K |
|
1984
United Parks & Resorts
PRKS
$2.07B
| $784K | ﹤0.01% |
71,125
+341
| +0.5% | +$9.33K |
|
1985
Caleres
CAL
$486M
| $783K | ﹤0.01% |
150,486
+6,362
| +4% | +$91.4K |
|
|
IMGN
1986
DELISTED
Immunogen Inc
IMGN
| $782K | ﹤0.01% |
229,317
+20,352
| +10% | +$89K |
|
|
PTLA
1987
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $782K | ﹤0.01% |
109,635
+1,171
| +1% | +$14.6K |
|
|
FLIC
1988
DELISTED
First of Long Island Corp
FLIC
| $781K | ﹤0.01% |
45,036
+6,943
| +18% | +$145K |
|
1989
Weis Markets
WMK
$1.78B
| $780K | ﹤0.01% |
18,719
+2,513
| +16% | +$96.1K |
|
|
TVRD
1990
Tvardi Therapeutics
TVRD
$22M
| $777K | ﹤0.01% |
1,633
-66
| -4% | -$35.9K |
|
|
RC
1991
Ready Capital
RC
$333M
| $776K | ﹤0.01% |
107,432
+5,750
| +6% | +$78.6K |
|
1992
Argan
AGX
$8.15B
| $774K | ﹤0.01% |
22,393
+652
| +3% | +$27K |
|
1993
Spok Holdings
SPOK
$237M
| $774K | ﹤0.01% |
72,364
+10,190
| +16% | +$109K |
|
1994
Collegium Pharmaceutical
COLL
$882M
| $773K | ﹤0.01% |
47,309
+1,746
| +4% | +$36K |
|
1995
Parsons
PSN
$4.93B
| $772K | ﹤0.01% |
24,141
+600
| +3% | +$23.3K |
|
1996
Madrigal Pharmaceuticals
MDGL
$11.9B
| $767K | ﹤0.01% |
11,494
+715
| +7% | +$59.6K |
|
1997
Ezcorp Inc
EZPW
$1.67B
| $766K | ﹤0.01% |
183,679
+8,964
| +5% | +$46.1K |
|
1998
Nicolet Bankshares
NIC
$3.63B
| $764K | ﹤0.01% |
13,998
+263
| +2% | +$17.7K |
|
1999
First Community Bankshares
FCBC
$902M
| $763K | ﹤0.01% |
32,731
+7,560
| +30% | +$208K |
|
2000
Arrow Financial
AROW
$644M
| $759K | ﹤0.01% |
30,652
+6,572
| +27% | +$193K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2020 Portfolio in Review
As of Q1 2020, RhumbLine Advisers held 2,980 positions worth $47.7B, down 20% from $59.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2020: portfolio turnover was 2.7%. RhumbLine Advisers opened 31 new positions and exited 49, leaving the 2,980-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q1 2020 buy was PPD, Inc. Common Stock: 58,466 shares worth $1.04M.
- RhumbLine Advisers added most to Prologis in Q1 2020, an estimated $22.7M increase.
- RhumbLine Advisers's biggest Q1 2020 reduction was Apple, cutting an estimated $70.6M.
- RhumbLine Advisers fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $34.9M.
- RhumbLine Advisers's ten largest holdings make up 20% of its $47.7B portfolio in Q1 2020.
- RhumbLine Advisers opened 31 new positions and closed 49 in Q1 2020.
- RhumbLine Advisers's portfolio value fell 20% quarter-over-quarter to $47.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.